Evaluating a standardized influenza vaccination program for hospitalized children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess whether a stakeholder-informed, standardized inpatient vaccination program can enhance influenza vaccination rates among hospitalized children in various U.S. pediatric health systems. Initially, a multidisciplinary team will be formed to create a best practice implementation guide for the vaccination program. Following this, the program will be piloted across three sites, and its effectiveness will be evaluated using an adaptive trial design across 12 health systems. The study will utilize established frameworks to measure the program's impact on vaccination rates.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* At least 6 months of age
* Admitted to an inpatient unit at a participating health system

Exclusion:

\- Admission to critical care sites or hematology-oncology services

Exclusion Criteria:

* At least 6 months of age
* Admitted to an inpatient unit at a participating health system

Exclusion:

\- Admission to critical care sites or hematology-oncology services

Where it's running

• Ann and Robert Lurie's Children Hospital of Chicago
  Chicago, Illinois, United States Recruiting
• Seattle Children's Hospital
  Seattle, Washington, United States Recruiting

Study contacts

• Principal investigator: Suchitra Rao — University of Colorado, Children's Hospital Colorado
• Study coordinator: Suchitra Rao
• Email: suchitra.rao@childrenscolorado.org
• Phone: 7207772823

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• High-dose vs standard-dose flu vaccine in adults with blood cancers on B-cell-depleting therapy

  This study tests whether a high-dose flu shot evokes a stronger immune response than a standard-dose shot in adults with hematologic cancers who recently had B-cell-depleting therapy.

  Recruiting Phase 2 Asan Medical Center · Seoul · NCT07926217

• Abbott ID NOW at the point of care for flu-like illness in long-term care facilities

  This trial tests whether the Abbott ID NOW rapid test at the point of care in long-term care facilities can help identify influenza sooner for residents 65 and older with fever and respiratory symptoms.

  Recruiting China Medical University Hospital · Taichung · NCT07846423

• Egg-based H5N8 influenza vaccine at multiple doses with or without adjuvant in healthy adults

  This trial tests whether an egg-based H5N8 flu vaccine, given at low to high doses with or without an adjuvant, is safe and can provoke a stronger immune response in healthy adults 18 and older.

  Recruiting at 16 sites Phase 1/2 Sanofi · Tempe, Arizona and 15 other locations · NCT07779408

• Safety and PK of Ingavirin Forte vs Ingavirin in healthy adults under fasting and fed conditions

  This early-phase study tests whether Ingavirin Forte (90 mg + 20 mg) is safe and how it behaves in the body compared with Ingavirin (90 mg) in healthy adults aged 18–45, under different meal conditions.

  Recruiting Phase 1 Valenta Pharm JSC · Saint Petersburg · NCT07645534

• Light-based immune boost to help prevent viral upper respiratory infections

  A daily handheld light therapy device is tested to see if it can lower how often adults at a military medical facility get colds, flu, or other upper respiratory infections.

  Recruiting Mike O'Callaghan Military Hospital · Nellis Air Force Base, Nevada · NCT07610967

• Virological Monitoring of Seasonal Respiratory Infections in France

  This project tests how often common respiratory viruses show up in patients seen by primary care doctors in metropolitan France during the fall and winter.

  Recruiting Institut National de la Santé Et de la Recherche Médicale, France · Paris · NCT07599449

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.